Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126093) titled 'High-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate Cancer' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Prostate Cancer
Intervention:
Combination Product: focal high-intensity focused ultrasound therapy combined with standard novel hormonal therapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2025
Ta...